Elyes Dahmane

456 total citations
14 papers, 321 citations indexed

About

Elyes Dahmane is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Elyes Dahmane has authored 14 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Elyes Dahmane's work include Pharmacogenetics and Drug Metabolism (5 papers), Estrogen and related hormone effects (3 papers) and Analytical Chemistry and Chromatography (2 papers). Elyes Dahmane is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Estrogen and related hormone effects (3 papers) and Analytical Chemistry and Chromatography (2 papers). Elyes Dahmane collaborates with scholars based in United States, Switzerland and Netherlands. Elyes Dahmane's co-authors include Jogarao Gobburu, Laurent A. Décosterd, Paul R. Hutson, Chantal Csajka, Elizabeth M. Jaffee, Matthew McCoy, Wojciech G. Lesniak, Charles M. Rudin, Viola Allaj and Olivier Petermann and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and Clinical Cancer Research.

In The Last Decade

Elyes Dahmane

13 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elyes Dahmane United States	7	102	99	57	35	30	14	321
Lifen Xu Switzerland	15	250 2.5×	34 0.3×	68 1.2×	66 1.9×	14 0.5×	28	600
Wei‐Xia Zhang China	10	177 1.7×	50 0.5×	14 0.2×	21 0.6×	21 0.7×	12	314
Jatinder Singh United States	13	190 1.9×	125 1.3×	16 0.3×	46 1.3×	27 0.9×	37	430
Yao‐Chung Wu Taiwan	8	198 1.9×	57 0.6×	41 0.7×	19 0.5×	6 0.2×	14	409
Hophil Min South Korea	13	200 2.0×	60 0.6×	28 0.5×	44 1.3×	18 0.6×	37	436
Haojun Yang United States	15	224 2.2×	115 1.2×	11 0.2×	20 0.6×	15 0.5×	21	569
Kamal M. Al-Shami United States	9	131 1.3×	110 1.1×	32 0.6×	42 1.2×	10 0.3×	12	309
Brooke M. Katzman United States	12	186 1.8×	78 0.8×	45 0.8×	55 1.6×	13 0.4×	26	406
Cynthia L. Martel United States	10	153 1.5×	162 1.6×	20 0.4×	9 0.3×	29 1.0×	16	551
AGM Mostofa Bangladesh	11	172 1.7×	87 0.9×	14 0.2×	45 1.3×	22 0.7×	20	489

Countries citing papers authored by Elyes Dahmane

Since Specialization

Citations

This map shows the geographic impact of Elyes Dahmane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyes Dahmane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyes Dahmane more than expected).

Fields of papers citing papers by Elyes Dahmane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyes Dahmane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyes Dahmane. The network helps show where Elyes Dahmane may publish in the future.

Co-authorship network of co-authors of Elyes Dahmane

This figure shows the co-authorship network connecting the top 25 collaborators of Elyes Dahmane. A scholar is included among the top collaborators of Elyes Dahmane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyes Dahmane. Elyes Dahmane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kasamon, Yvette L., Elyes Dahmane, Yuching Yang, et al.. (2023). FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma. Clinical Cancer Research. 30(1). 17–22. 17 indexed citations

Li, Shuhui, Homa K. Ahmadzia, Dong Guo, et al.. (2021). Population pharmacokinetics and pharmacodynamics of Tranexamic acid in women undergoing caesarean delivery. British Journal of Clinical Pharmacology. 87(9). 3531–3541. 20 indexed citations

Strauss, Erik, Elyes Dahmane, Dong Guo, et al.. (2020). A Pharmacokinetic and Pharmacodynamic Investigation of an ε-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass. Journal of Cardiothoracic and Vascular Anesthesia. 35(2). 406–417. 6 indexed citations

Dahmane, Elyes, Paul R. Hutson, & Jogarao Gobburu. (2020). Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin. Clinical Pharmacology in Drug Development. 10(1). 78–85. 28 indexed citations

Dahmane, Elyes, Kathy Tang, Jogarao Gobburu, et al.. (2019). Clinical Pharmacology‐Driven Translational Research to Optimize Bedside Therapeutics of Sotalol Therapy. Clinical and Translational Science. 12(6). 648–656. 3 indexed citations

Kumar, Dhiraj, Ala Lisok, Elyes Dahmane, et al.. (2018). Peptide-based PET quantifies target engagement of PD-L1 therapeutics. Journal of Clinical Investigation. 129(2). 616–630. 103 indexed citations

Dahmane, Elyes, et al.. (2018). Development and validation of a HPLC‐UV assay for quantification of levetiracetam concentrations in critically ill patients undergoing continuous renal replacement therapy. Biomedical Chromatography. 32(8). e4257–e4257. 6 indexed citations

Rochat, Bertrand, et al.. (2015). Improved Investigations in Drug Safety by More In-Depth Individual Pharmacokinetics Using High-Resolution Mass Spectrometry. Therapeutic Drug Monitoring. 37(2). 141–146. 2 indexed citations

Dahmane, Elyes, Julien Boccard, Chantal Csajka, et al.. (2014). Quantitative monitoring of tamoxifen in human plasma extended to 40 metabolites using liquid-chromatography high-resolution mass spectrometry: new investigation capabilities for clinical pharmacology. Analytical and Bioanalytical Chemistry. 406(11). 2627–2640. 32 indexed citations

10.

Dorchies, O.M., Elyes Dahmane, Laurent A. Décosterd, et al.. (2014). G.P.105. Neuromuscular Disorders. 24(9-10). 826–826.

11.

Dorchies, O.M., Elyes Dahmane, Hesham M. Ismail, et al.. (2013). The Anticancer Drug Tamoxifen Counteracts the Pathology in a Mouse Model of Duchenne Muscular Dystrophy. American Journal Of Pathology. 182(2). 485–504. 69 indexed citations

12.

Dahmane, Elyes, Lucien Perey, Alexandre Bodmer, et al.. (2011). Population Pharmacokinetics of Tamoxifen and three of its metabolites in Breast Cancer patients. 2 indexed citations

13.

Dahmane, Elyes, Thomas Mercier, Boris Zanolari, et al.. (2010). An ultra performance liquid chromatography–tandem MS assay for tamoxifen metabolites profiling in plasma: First evidence of 4′-hydroxylated metabolites in breast cancer patients. Journal of Chromatography B. 878(32). 3402–3414. 32 indexed citations

14.

Dahmane, Elyes, Chantal Csajka, Lucien Perey, et al.. (2010). Abstract PD05-09: Prospective Assessment of CYP2D6 by Genotyping, Phenotyping and Measurement of Tamoxifen, 4-Hydroxy-Tamoxifen and Endoxifen in Breast Cancer Patients Treated with Tamoxifen. Cancer Research. 70(24_Supplement). PD05–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact